摘要
目的探讨临床药师在多发性骨髓瘤患者治疗团队中的作用。方法回顾分析1例多发性骨髓瘤患者历次诊疗用药情况及静脉彩超结果,分析患者血栓形成的原因及历次抗凝药物的使用。结果该例多发性骨髓瘤患者左腿胫后静脉血栓形成与沙利度胺及地塞米松联合使用有密切关系,临床药师为患者进行了后续治疗方案的推荐。结论临床药师能够在治疗团队中提供科学、有效的参考依据,协同临床医生制定药物治疗方案,提供药学监护。
Objective To discuss the role of clinical pharmacists in multiple myeloma patients’ therapeutic teams. Methods Clinical pharmacist retrospected each therapeutic scheme and the venous ultrasound results of the patient, and analysed the factors of thrombosis and anticoagulant therapy for drug use of this patient. Results The combined use of thalidomide and dexamethasone was closely related to deep vein thrombosis of the patient. Clinical pharmacist recommended a follow-up treatment prescription for the patient. Conclusions Clinical pharmacists can provide scientific and effective reference for the treatment team, and help doctors formulate drug treatment prescription, and provide pharmaceutical care.
作者
刘艳秋
宋琳婧
古曦
王丽
游丽娜
LIU Yanqiu;SONG Linjing;GU Xi;WANG Li;YOU Lina(Yan’ An Hospital of Kunming City / Yan’ an Affiliated Hospital of Kunming Medical College, Kunming, Yunnan, 650051, China)
出处
《肿瘤药学》
CAS
2018年第2期288-291,共4页
Anti-Tumor Pharmacy
关键词
多发性骨髓瘤
静脉血栓
沙利度胺
Multiple myeloma
Venous thromboembolism
Thalidomide